azomycin has been researched along with nad in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Alvaro, R; Fiorentini, KM; Lu, AY; West, SB; Wislocki, PG; Wolf, FJ | 1 |
| Bloomer, WD; Ji, M; Papadopoulou, MV; Rao, MK | 1 |
| Baeza, I; Chena, MA; Elizondo, S; Nogueda, B; Rodríguez-Páez, L; Wong, C | 1 |
| Hall, BS; Wilkinson, SR | 1 |
| Hall, BS; Meredith, EL; Wilkinson, SR | 1 |
| Campos-Fernández, L; Cortés-Barberena, E; Garduño-Juárez, R; Mares-Sámano, S; Ortiz-Muñiz, R; Soriano-Correa, C | 1 |
| Luo, J; Mu, X; Wang, Z; Yang, Q; Zhao, Y | 1 |
| Abrahams, KA; Bashiri, G; Batt, SM; Besra, GS; Gurcha, SS; Veerapen, N | 1 |
8 other study(ies) available for azomycin and nad
| Article | Year |
|---|---|
Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation.
Topics: Alkylation; Animals; Chromatography, High Pressure Liquid; Cysteine; Female; Male; Microsomes, Liver; Muscles; NAD; NADP; NADPH-Ferrihemoprotein Reductase; Nitroimidazoles; Nucleic Acids; Nucleotides; Protein Binding; Rats; Ronidazole; Swine | 1982 |
Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257).
Topics: Adenosine Monophosphate; Animals; Chromatography, High Pressure Liquid; Cytotoxins; Enzyme Inhibitors; Humans; Imidazoles; Microsomes, Liver; NAD; NAD(P)H Dehydrogenase (Quinone); NADP; Nitroimidazoles; Oxidation-Reduction; Oxygen; Quinolines; Rats | 2003 |
Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains.
Topics: Alcohol Oxidoreductases; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kinetics; Mice; Models, Chemical; NAD; Nifurtimox; Nitroimidazoles; Oxamic Acid; Species Specificity; Time Factors; Trypanocidal Agents; Trypanosoma cruzi; Trypanosomiasis | 2005 |
Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation.
Topics: Biotransformation; Chagas Disease; Chromatography, Liquid; DNA Damage; Glyoxal; Guanosine; Humans; Hydroxylamine; Imidazoles; Kinetics; Mass Spectrometry; NAD; Nitroimidazoles; Nitroreductases; Prodrugs; Protozoan Proteins; Spectrophotometry; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis, African | 2012 |
Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.
Topics: Benzoquinones; Escherichia coli; Kinetics; Mitochondria; Molecular Targeted Therapy; NAD; Nifurtimox; Nitroimidazoles; Nitroreductases; Prodrugs; Protozoan Proteins; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Substrate Specificity; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2012 |
Imidazole and nitroimidazole derivatives as NADH-fumarate reductase inhibitors: Density functional theory studies, homology modeling, and molecular docking.
Topics: Density Functional Theory; Enzyme Inhibitors; Humans; Imidazoles; Molecular Docking Simulation; NAD; Nitroimidazoles; Oxidoreductases Acting on CH-CH Group Donors | 2022 |
Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha.
Topics: Antineoplastic Agents; Aspartic Acid; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Cytochromes c; Dicumarol; Female; Glutathione; Humans; Hypoxia; Micelles; NAD; NADP; Nitroimidazoles; Oxygen; Phosphates; Polyethylene Glycols; Polymers; Quinones; Sorafenib; Thioredoxins | 2022 |
DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Cell Wall; Drug Resistance; Kinetics; Molecular Targeted Therapy; Mycobacterium tuberculosis; NAD; Nitroimidazoles; Prodrugs; Spectrophotometry | 2023 |